BDFN
GILD icon

Bond & Devick Financial Network’s Gilead Sciences GILD Stock Holding History

Bond & Devick Financial Network’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Hold
2,156
– – 0.07% 167
2026
Q1 		$300K Sell
2,156
-20
-0.9% -$2.8K 0.08% 147
2025
Q4 		$267K Hold
2,176
– – 0.08% 153
2025
Q3 		$242K Buy
+2,176
New +$247K 0.07% 157

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bond & Devick Financial Network's GILD Position: Q2 2026 in Review

Bond & Devick Financial Network held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,156 shares worth $272K. The position accounts for 0.07% of the portfolio, ranked #167.

Bond & Devick Financial Network first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $300K in Q1 2026. 2,293 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bond & Devick Financial Network held 2,156 shares of Gilead Sciences worth $272K as of Q2 2026.
  • Bond & Devick Financial Network left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.07% of Bond & Devick Financial Network's portfolio in Q2 2026, its #167 holding.
  • Bond & Devick Financial Network first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • Bond & Devick Financial Network's Gilead Sciences position peaked at $300K in Q1 2026.
  • 2,293 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bond & Devick Financial Network's 13F filing for Q2 2026, filed 16 Jul 2026.